Search
alogliptin/metformin (Kazano)
Indications:
- diabetes mellitus type 2
- for use in combination with diet & exercise [1]
Dosage: tablet
Adverse effects:
- rhinorrhea
- upper respiratory tract infection
- sore throat
- diarrhea
- headache
- hypertension
- back pain
- urinary tract infection
- black box warning for lactic acidosis due to metformin
General
pharmacologic combination
References
- FDA News Release: Jan. 25, 2013
FDA approves three new drug treatments for type 2 diabetes
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336942.htm
Components
alogliptin (Nesina)
metformin (Glucophage)